[U] So... I Will Likely Forward A Copy Of This Post To USDC Judge Cote's Chambers... And To The FTC's Offices In Manhattan...

UPDATED: 12.13.2025 AM -- The stock of Q/C Technologies, which was at $7.93 a few days before Martin signed on as a strategic advisor. . . is now at $4.77, on the NASDAQ -- it has nearly been cut in half in the three days since he joined the team. Charming. End, updated portion.

I admit that I went down a bit of a rabbit hole, trying to figure out what -- exactly it is -- that the '34 Act reporting company calling itself QC Technologies actually. . . does.

It sent out splashy press releases a few weeks ago saying it was now focusing on the development of "quantum class" computing solutions that would rely on photonic / speed of light technology (whatever that might mean!) the company had licensed in. . . from. . . somewhere. Fine.

BUT. . . TNF Pharmaceuticals (which was only a name change -- not a dissolution, or divestiture) still maintains an active website, promoting the drugs-in-development at left.

Martin is being paid $150,000 a year (in cash) to act as a strategic advisor to this company -- and getting warrants and restricted stock, vesting over time.

So, as far as I can tell -- and I did some looking -- I looked in the official SEC filings, as well. . . the company has nowhere said it has divested the pharmaceuticals R&D businesses, nor that it has ceased all work on those "med pot/CBD" projects. [The TNF website still makes health claims for them, too.]

My point? The final orders the FTC won before USDC Judge Cote in 2021-22, in Manhattan (and subsequently affirmed by the US Supreme Court) expressly prohibit Martin from acting in any paid form, for any company in the pharmaceuticals businesses.

He cannot simply change the company's name -- as say they are "de-emphasizing" the medical pot development biz. . . in order to take cash for helping to sell on or close out these pharmaceutical clinical trial projects. This is exactly what his USDC final injunctions / FTC banning-orders forbid him from doing.

Look -- I get it: just last week, his supposed portfolio of pharma related and computing related stock investments (and shorts) -- one he was crowing about, daily on his YouTube live-streams... utterly imploded. Went to zero (on a stupidly specific short he put on, against a drug development co.), and he was outright liquidated -- for margin calls. [Just like in 2014-15, right?!]

He is flat out of cash flow runway. So, he needs to feed his baby, and pay his rent, in New York. AND so. . . he signs on to a serial failure of a public company. For cash. But he cannot violate his lifetime banning order, in doing so.

Onward, resolutely.

See ya' in the funny papers, man.

नमस्ते